PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FA8VB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,570
Award facts
- Contract value 100% obligated
- $37,570.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,570.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on July 14, 2025, with a completion date of July 15, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award carries no set-aside designation, indicating competitive procurement. AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems.
This delivery order exemplifies AmerisourceBergen's role within the DLA's pharmaceutical supply chain infrastructure. The company maintains a substantial prime indefinite delivery contract valued at $999,999,999.00 through December 2026, which serves as the umbrella vehicle enabling the delivery of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive portfolio of federal awards demonstrates consistent capability in fulfilling diverse medical supply requirements across multiple therapeutic domains, positioning the company as a key strategic partner for the Defense Health Agency and other federal healthcare systems. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with potential multiple awards across separate regions, indicating continued reliance on qualified distributors like AmerisourceBergen to meet defense medical supply needs.
Quick answers
Who was awarded contract SPE2D825FA8VB?
SPE2D825FA8VB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2D825FA8VB worth?
The government has obligated $37,570 on SPE2D825FA8VB.
Is contract SPE2D825FA8VB an order under another contract?
Yes. SPE2D825FA8VB is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D825FA8VB competed?
The extent of competition for SPE2D825FA8VB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award